Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1956 4
1957 2
1958 1
1961 1
1963 2
1964 4
1965 4
1966 8
1967 10
1968 2
1969 4
1970 2
1971 7
1972 4
1973 5
1974 5
1975 2
1976 3
1977 2
1978 2
1980 2
1981 5
1982 5
1983 5
1984 2
1985 7
1986 13
1987 10
1988 11
1989 23
1990 13
1991 12
1992 13
1993 6
1994 11
1995 8
1996 11
1997 16
1998 15
1999 20
2000 16
2001 23
2002 24
2003 21
2004 29
2005 30
2006 24
2007 36
2008 17
2009 26
2010 27
2011 31
2012 34
2013 36
2014 28
2015 31
2016 26
2017 35
2018 42
2019 47
2020 51
2021 51
2022 60
2023 59
2024 60

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,056 results

Results by year

Filters applied: . Clear all
Page 1
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma.
Khalfaoui L, Symon FA, Couillard S, Hargadon B, Chaudhuri R, Bicknell S, Mansur AH, Shrimanker R, Hinks TSC, Pavord ID, Fowler SJ, Brown V, McGarvey LP, Heaney LG, Austin CD, Howarth PH, Arron JR, Choy DF, Bradding P. Khalfaoui L, et al. Among authors: brown v. Allergy. 2022 Oct;77(10):2974-2986. doi: 10.1111/all.15376. Epub 2022 May 25. Allergy. 2022. PMID: 35579040 Free PMC article. Clinical Trial.
Valaciclovir for Epstein-Barr Virus Suppression in Moderate-to-Severe COPD: A Randomized Double-Blind Placebo-Controlled Trial.
Linden DA, Guo-Parke H, McKelvey MC, Einarsson GG, Lee AJ, Fairley DJ, Brown V, Lundy G, Campbell C, Logan D, McFarland M, Singh D, McAuley DF, Taggart CC, Kidney JC. Linden DA, et al. Among authors: brown v. Chest. 2023 Sep;164(3):625-636. doi: 10.1016/j.chest.2023.03.040. Epub 2023 Apr 1. Chest. 2023. PMID: 37011709 Free PMC article. Clinical Trial.
Reaction time deficits and Parkinson's disease.
Gauntlett-Gilbert J, Brown VJ. Gauntlett-Gilbert J, et al. Among authors: brown vj. Neurosci Biobehav Rev. 1998 Oct;22(6):865-81. doi: 10.1016/s0149-7634(98)00014-1. Neurosci Biobehav Rev. 1998. PMID: 9809316 Review.
Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma.
Howell I, Yang F, Brown V, Cane J, Marchi E, Azim A, Busby J, McDowell PJ, Diver SE, Borg C, Heaney LG, Pavord ID, Brightling CE, Chaudhuri R, Hinks TSC. Howell I, et al. Among authors: brown v. J Allergy Clin Immunol. 2024 Aug 2:S0091-6749(24)00777-2. doi: 10.1016/j.jaci.2024.07.020. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39097197 Free article.
[A marathon runner with rhabdomyolysis].
Abbas M, Brown V, Rietveld AP, Hoek AE. Abbas M, et al. Among authors: brown v. Ned Tijdschr Geneeskd. 2019 Jan 9;163:D2848. Ned Tijdschr Geneeskd. 2019. PMID: 30637999 Dutch.
A Patient With Blue Ears.
Muttardi K, Rubin A, Brown VL. Muttardi K, et al. Among authors: brown vl. JAMA Dermatol. 2016 Apr;152(4):465-6. doi: 10.1001/jamadermatol.2015.4861. JAMA Dermatol. 2016. PMID: 26747687 No abstract available.
1,056 results